Matt Krisiloff

Overview

Matt Krisiloff is an angel investor and CEO of Conception, a biotechnology company specializing in reproductive medicine. He co-founded SciFounders, an angel investment group that supports early-stage science-driven startups with investments of $400,000 for 10% equity. SciFounders primarily invests in sectors such as biotechnology, drug delivery, and diagnostics, targeting pre-seed, seed, and Series A stages. The firm emphasizes providing not only financial support but also mentorship and access to a valuable network, easing the transition for technical founders into leadership roles. SciFounders encourages founder-led fundraising efforts, emphasizing the importance of choosing the right partners who are patient, share the company's vision, and can contribute positively to the company's trajectory. While equity investment is at the core of their strategy, SciFounders is also aware of the benefit of non-dilutive capital sources and promotes exploration of government grants, private funding, and strategic partnerships. In addition to his role at Conception and SciFounders, Krisiloff has been involved in various initiatives to support biotech founders. He has raised approximately $100 million for biotech projects and has shared insights on effective fundraising strategies for founder-led biotech companies. His investment philosophy centers on empowering scientists to lead their own companies, advocating for founder control and autonomy in the biotech sector. Krisiloff's background includes co-founding Y Combinator Research’s basic income project and founding Conception, a biotechnology company working on reproductive medicine. His experience in science-driven entrepreneurship and venture incubation informs his approach to supporting early-stage biotech startups, focusing on both financial investment and strategic guidance to foster innovation and growth in the sector.

Investment Focus

• Founder-led startups
• Biotechnology focus
• Pre-seed to Series A stages

Portfolio Companies